Caribou Biosciences Competitors: 10 Similar Biotech

Caribou Biosciences — investors and similar companies (65)

Companies comparable to Caribou Biosciences in Biotech, headquartered in Berkeley, California, ranked by how much of Caribou Biosciences's verified investor base they share. 147 of the companies below have at least one backer in common with Caribou Biosciences.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 17
• Total disclosed funding: $40M
• Latest tracked round: Series C (2021-03-03)
• Sector: Biotech
• Headquarters: Berkeley, California

• Farallon Capital Management
• PFM Health Sciences
• Ridgeback Capital Investments
• AbbVie Ventures
• Adage Capital Partners LP
• Avego Bioscience Capital
• Avidity Partners
• Invus
• Janus Henderson Investors
• LifeSci Venture Partners
• The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP)
• Monashee Investment Management, LLC
• Point72
• Tekla Capital Management LLC
• Heritage Medical Systems
• Maverick Ventures
• Pontifax Global Food and Agriculture Technology Fund
• Ajax Therapeutics — shares Point72
• Evommune — shares Avego Bioscience Capital
• Innovaccer — shares Avidity Partners
• EGenesis — shares Farallon Capital Management
• Metagenomi — shares PFM Health Sciences +1
• Diagonal Therapeutics — shares Janus Henderson Investors
• Scipher Medicine
• Windward Bio — shares Janus Henderson Investors
• Curevo — shares Janus Henderson Investors
• Autobahn Therapeutics — shares Invus
• ImCheck Therapeutics — shares Invus
• Infleqtion — shares Maverick Ventures
• DTx Pharma — shares Janus Henderson Investors
• Mirador Therapeutics — shares Point72 +2
• Alvotech — shares Farallon Capital Management
• LifeMine Therapeutics — shares Invus
• ProfoundBio — shares Janus Henderson Investors
• Verve Therapeutics — shares Janus Henderson Investors
• SQZ Biotech — shares Invus
• Pentera — shares Farallon Capital Management
• Ovid Therapeutics — shares Janus Henderson Investors
• Disc Medicine — shares Janus Henderson Investors
• Achilles Therapeutics — shares Invus
• Caldera Therapeutics — shares Janus Henderson Investors
• Point Biopharma — shares Farallon Capital Management
• Angitia Biopharmaceuticals — shares Janus Henderson Investors
• BioCatch — shares Maverick Ventures
• Encoded Therapeutics — shares Farallon Capital Management
• ILiAD Biotechnologies — shares Janus Henderson Investors
• ADARx Pharmaceuticals — shares Invus
• AgomAb Therapeutics — shares Invus
• Korsana Biosciences — shares Janus Henderson Investors
• Elektrofi — shares Janus Henderson Investors
• BioTheryX — shares Farallon Capital Management +2
• Flame Biosciences — shares Janus Henderson Investors
• Moderna Therapeutics — shares Invus
• Delfi Diagnostics — shares Point72
• Crossover Health — shares Avidity Partners +1
• Escient Pharmaceuticals — shares Avego Bioscience Capital +1
• Asher Bio — shares Janus Henderson Investors
• Obsidian Therapeutics — shares Janus Henderson Investors
• Repertoire Immune Medicines — shares Invus
• Aktis Oncology — shares Janus Henderson Investors
• Selecta Biosciences — shares Ridgeback Capital Investments
• Cold Quanta — shares Maverick Ventures
• MBrace Therapeutics — shares Avidity Partners
• Skyryse
• Prometheus Biosciences — shares Point72 +1

Caribou Biosciences funding profile · All research reports